221 related articles for article (PubMed ID: 12851485)
1. E2F1 and c-Myc in cell growth and death.
Matsumura I; Tanaka H; Kanakura Y
Cell Cycle; 2003; 2(4):333-8. PubMed ID: 12851485
[TBL] [Abstract][Full Text] [Related]
2. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
3. E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.
Elliott MJ; Dong YB; Yang H; McMasters KM
Clin Cancer Res; 2001 Nov; 7(11):3590-7. PubMed ID: 11705881
[TBL] [Abstract][Full Text] [Related]
4. ARF differentially modulates apoptosis induced by E2F1 and Myc.
Russell JL; Powers JT; Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Mol Cell Biol; 2002 Mar; 22(5):1360-8. PubMed ID: 11839803
[TBL] [Abstract][Full Text] [Related]
5. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
Lindström MS; Wiman KG
Oncogene; 2003 Aug; 22(32):4993-5005. PubMed ID: 12902982
[TBL] [Abstract][Full Text] [Related]
6. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis.
Rogoff HA; Pickering MT; Debatis ME; Jones S; Kowalik TF
Mol Cell Biol; 2002 Aug; 22(15):5308-18. PubMed ID: 12101227
[TBL] [Abstract][Full Text] [Related]
7. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
8. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination.
Tanaka H; Matsumura I; Ezoe S; Satoh Y; Sakamaki T; Albanese C; Machii T; Pestell RG; Kanakura Y
Mol Cell; 2002 May; 9(5):1017-29. PubMed ID: 12049738
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
10. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
11. The role of the transcription factor DP in apoptosis.
Hitchens MR; Robbins PD
Apoptosis; 2003 Oct; 8(5):461-8. PubMed ID: 12975577
[TBL] [Abstract][Full Text] [Related]
12. Myc requires distinct E2F activities to induce S phase and apoptosis.
Leone G; Sears R; Huang E; Rempel R; Nuckolls F; Park CH; Giangrande P; Wu L; Saavedra HI; Field SJ; Thompson MA; Yang H; Fujiwara Y; Greenberg ME; Orkin S; Smith C; Nevins JR
Mol Cell; 2001 Jul; 8(1):105-13. PubMed ID: 11511364
[TBL] [Abstract][Full Text] [Related]
13. Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins.
Alevizopoulos K; Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5322-33. PubMed ID: 9311992
[TBL] [Abstract][Full Text] [Related]
14. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation.
Raveh T; Droguett G; Horwitz MS; DePinho RA; Kimchi A
Nat Cell Biol; 2001 Jan; 3(1):1-7. PubMed ID: 11146619
[TBL] [Abstract][Full Text] [Related]
15. TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis.
Dugan KA; Wood MA; Cole MD
Oncogene; 2002 Aug; 21(38):5835-43. PubMed ID: 12185582
[TBL] [Abstract][Full Text] [Related]
16. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
17. The c-MYC-interacting proapoptotic tumor suppressor BIN1 is a transcriptional target for E2F1 in response to DNA damage.
Cassimere EK; Pyndiah S; Sakamuro D
Cell Death Differ; 2009 Dec; 16(12):1641-53. PubMed ID: 19629135
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
19. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of E2F-1-regulating proteins and activation of E2F-1 during CD95-induced death of thymocytes.
Bi B; Littlewood NK; Crispe IN
Immunology; 2001 Sep; 104(1):37-42. PubMed ID: 11576218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
